On Thursday, United Therapeutics Corporation (NASDAQ:UTHR) saw three of its insiders complete stock dispositions. The company’s Chief Financial Officer, John Maxim Ferrari, completed the largest transaction, unloading 10,000 shares of Common Stock, directly, for $86.44 per share. This is just the most recent stock disposition to be executed by the insider, as he has consistently been unloading shares over the past quarter. In July Ferrari sold 10,000 shares for $89.74 per share, after disposing of shares throughout May, June, and July.
The second insider to unload stock at United Therapeutics is Director Christopher Patusky, who sold 5,000 shares of Common Stock for a weighted average price of $88.23 per share. This is the insider’s fourth disposition of the fiscal year so far, with his latest transaction dating back to May.
And finally, the company’s Chief Executive Officer, Martine Rothblatt, disposed of 4,115 shares of Common Stock, directly, for a weighted price of $88.39 per share. Furthermore, all of the mentioned insiders also exercised their use of stock options in their transactions.